Literature DB >> 3015081

Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology.

D Potratz, B Brake, H P Dienes, T F Schulz, M Hosp, M P Dierich, D Falke.   

Abstract

The adrenal glands were shown to be the most severely infected organs in the early phase of HSV-1 infections (up to 10 days p.i.) after i.p. infections in mice. Virus could be isolated from the adrenal glands as early as one hour after infection with pathogenic and apathogenic strains. Infection of the adrenal glands is a result of viremia. The content of HSV-1 (5 strains) was much higher in the adrenals than in spleen and liver. It peaked at 3-4 days p.i. compared to 1-2 days in spleen and liver. Only strain 17 syn+ produced low tissue titres in the adrenal glands. Morphologic alterations by HSV-1 infections commenced with distinct foci 2 days after infection in the zona fasciculata, detected immunohistochemically by HSV-specific peroxidase-staining. Necrotic cells could be observed. The foci became confluent until day 4 and remained in this status up to day 7 p.i. During infection immunocompetent cells (macrophages, granulocytes, many T-helper--but only few T-cytotoxic/suppressor lymphocytes) could be observed. On day 10 p.i. the viral antigen had been completely eliminated. In contrast, intraperitoneal infections with 5 strains of HSV-2 resulted in infection of the adrenal glands only to a low degree. The titer of virus was low (exception: strain HG 52). This correlates well with the type of disease produced by either HSV-1 or 2. By comparing the replication of different strains of HSV-1 and 2, three types of "tropism" after i.p. infection of mice can be distinguished.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015081     DOI: 10.1007/bf01317371

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Latent herpetic infections following experimental viraemia.

Authors:  M L Cook; J G Stevens
Journal:  J Gen Virol       Date:  1976-04       Impact factor: 3.891

2.  Acute and recurrent herpes simplex in several strains of mice.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1981-07       Impact factor: 3.891

3.  Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment.

Authors:  A Rösen; H Gelderblom; G Darai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

4.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

5.  Investigation of the virulence genes of herpes simplex virus 2 by experimental infection in vivo with defined intertypic recombinants of a virulent HSV-2 X an avirulent HSV-1.

Authors:  A Rösen; G Darai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

6.  Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.

Authors:  L Caspary; B Schindling; S Dundarov; D Falke
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Inhibition by indomethacin of in vitro reactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia.

Authors:  I Kurane; Y Tsuchiya; T Sekizawa; K Kumagai
Journal:  J Gen Virol       Date:  1984-10       Impact factor: 3.891

8.  Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment.

Authors:  R L Thompson; G V Devi-Rao; J G Stevens; E K Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.

Authors:  R L Thompson; J G Stevens
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

10.  Enhancement of antibody formation against herpes simplex virus in mice by the T-cell mitogen bestatin.

Authors:  A Knoblich; W E Müller; V Harle-Grupp; D Falke
Journal:  J Gen Virol       Date:  1984-10       Impact factor: 3.891

View more
  13 in total

1.  The region 0.7615-0.796 m.u. of the HSV-1 genome determines suppression of humoral antibody formation against herpes simplex virus.

Authors:  K Wollert; T el Ansari; A Rösen-Wolff; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Replication of herpes simplex virus type 1 and 2 in the medulla of the adrenal gland after vaginal infection of mice.

Authors:  J Podlech; F Hengerer; M Fleck; I Walev; D Falke
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; Juan M Alfaro; Fernando Valdivieso
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies.

Authors:  H Wiegand; H P Dienes; P Schirmacher; J Podlech; K Bohl; M Bohle; D Neumann-Haefelin; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands.

Authors:  E Peles; H Rosen; G Darai; A Rösen-Wolff; Y Becker
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies.

Authors:  J Podlech; K Weise; D Falke
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Spread of herpes simplex virus type-1 (Miyama +GC strain) to the central nervous system after intraperitoneal inoculation: the role of the myenteric plexus of the gut.

Authors:  H Irie; Y Harada; H Yoshihashi; T Kimura; M Kojima; M Kataoka; M Saito; Y Sugawara; W Mori
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice.

Authors:  C Berkowitz; M Moyal; A Rösen-Wolff; G Darai; Y Becker
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).

Authors:  H Minagawa; S Sakuma; S Mohri; R Mori; T Watanabe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor.

Authors:  B A Lidbury; I A Ramshaw; M S Rolph; W B Cowden
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.